Literature DB >> 10369205

Assisted reproduction for testicular failure: management of germ cell maturation arrest.

J Tesarik1, E Greco.   

Abstract

The availability of current, state of the art technology has enabled an efficient treatment in cases of infertility caused by testicular failure in which mature spermatozoa or late elongated spermatids can be recovered from the ejaculate or the testis. In those patients in whom only germ cells at earlier stages of spermatogenesis are present, results of the currently available treatments are still inconsistent and largely unpredictable, although some encouraging developments have been achieved over the past year. These new results suggest that developmental failure after fertilization with immature germ cells is mainly due to germ cell apoptosis and shows that an efficient selection of healthy germ cells can be achieved by in-vitro culture. In some cases, this method also allows premeiotic germ cells to achieve in-vitro transmeiotic maturation and thus enables men with in-vivo premeiotic maturation arrest to father a child.

Entities:  

Mesh:

Year:  1999        PMID: 10369205     DOI: 10.1097/00001703-199906000-00009

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  3 in total

1.  Analysis of STAG3 variants in Chinese non-obstructive azoospermia patients with germ cell maturation arrest.

Authors:  Wen Liu; Xuan Gao; Haobo Zhang; Ran Liu; Yongzhi Cao; Ruimei Yu; Ge Fang; Jinlong Ma; Shidou Zhao
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

Review 2.  Diagnostic and therapeutic testis biopsy.

Authors:  P T Chan; P N Schlegel
Journal:  Curr Urol Rep       Date:  2000-12       Impact factor: 2.862

Review 3.  Sperm retrieval in infertile males: comparison between testicular sperm extraction and testicular sperm aspiration techniques.

Authors:  Hamisu M Salihu; Muktar H Aliyu
Journal:  Wien Klin Wochenschr       Date:  2003-06-24       Impact factor: 2.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.